Forget a Cash ISA! I’d aim to make a passive income with these 2 FTSE 100 dividend stocks

I think these two FTSE 100 (INDEXFTSE:UKX) income shares appear to offer favourable prospects when compared to a Cash ISA.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Since the best returns available on a Cash ISA are currently around 1.5%, buying FTSE 100 dividend shares could prove to be a shrewd move.

In many cases, it is possible to double, or even treble, your passive income when compared to Cash ISA rates.

With interest rates set to remain at their current level, or even fall, over the next few years, now could be a good time to buy these two large-cap income shares. They appear to have sound strategies that could produce capital growth alongside their income returns.

AstraZeneca

With a 3.1% dividend yield, AstraZeneca (LSE: AZN) may not be among the highest-yielding shares in the FTSE 100. However, the pharmaceutical company’s dividend growth prospects could make it a sound income opportunity for the long run.

Its recent updates have shown that its pipeline has improved dramatically in recent years after an ambitious investment programme. This could position the company for growth in a world where demographic challenges may catalyse demand for a wide range of healthcare products and services.

AstraZeneca’s defensive business model may prove to be attractive to many investors during what is a period of significant economic and political risk.

Furthermore, with its dividend expected to be covered 1.3 times by net profit in the current year, there seems to be scope for its shareholder payouts to rise at a brisk pace. This could lead to a strong and dependable passive income stream for its investors that catalyses its share price over the long run.

British Land

Real estate investment trust (REIT) British Land (LSE: BLND) is a very different investment proposition than AstraZeneca. The property company is facing a period of disruption across much of its asset base, with demand for retail units expected to come under pressure over the medium term as online shopping becomes increasingly popular.

This could cause rents to decline, which may put the company’s dividend growth rate under a degree of pressure. However, with British Land shifting its focus away from retail and towards faster-growing areas such as flexible office space, it seems to have a sound strategy that could lead to improving financial performance in the long run.

Furthermore, investors appear to have factored in the risks facing the business. It trades on a price-to-book (P/B) ratio of just 0.6, while its dividend yield of 5.4% is among the highest yields currently available in the FTSE 100.

Certainly, British Land may prove to be a relatively risky stock to own in the short run, as it aims to transition towards assets that have greater growth potential. For long-term income investors, now could be the right time to buy a slice of the business based on its high income return and wide margin of safety. It could offer high total returns in the coming years.

Peter Stephens owns shares of AstraZeneca and British Land Co. The Motley Fool UK has recommended AstraZeneca and British Land Co. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Man hanging in the balance over a log at seaside in Scotland
Investing Articles

Has the BP share price rally just run out of steam?

Andrew Mackie looks beyond today’s BP share price fall to explain why cash flow and the oil cycle still support…

Read more »

Happy woman commuting on a train and checking her mobile phone while using headphones
Investing Articles

Barclays shares surge: stick or twist?

Barclays shares surged on Wednesday after the US and Iran announced a ceasefire agreement for two weeks. But there's more…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

What would £10,000 invested in Aviva shares 5 years ago be worth today?

Aviva shares have outperformed the FTSE 100 over the past five years. And the dividends have been impressive too. But…

Read more »

Senior couple crossing the road on a city street. They are walking with shopping bags while Christmas shopping.
Investing Articles

Could these 8 FTSE 250 shares turn £20,000 into £297,276 within 25 years?

James Beard reckons it’s possible to use dividend shares to create long-term wealth. But could his strategy work with these…

Read more »

British pound data
Investing Articles

Could AI bring on the mother of all stock market crashes?

Some are predicting AI will lead to a stock market crash like we’ve never seen before. James Beard considers how…

Read more »

Couple working from home while daughter watches video on smartphone with headphones on
Investing Articles

How did Rolls-Royce shares add £5bn in market cap in one day?

Rolls-Royce shares have just had a brilliant day. Is this a sign the share price is about to go on…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing Articles

How much would someone need in an ISA to target a £1,000 monthly passive income?

Dr James Fox explains how a novice investor could leverage an empty ISA to target a passive income in excess…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
US Stock

Down 10% this year, this S&P 500 banking giant looks super-cheap

Jon Smith flags a S&P 500 stock that’s had a rough few months but could start to rally if his…

Read more »